首页> 外文OA文献 >Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives
【2h】

Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives

机译:环状叔氨基磺酸盐:N和O取代的乙酰磺胺衍生物选择性抑制与肿瘤相关的碳酸酐酶IX和XII

摘要

Carbonic anhydrase (hCA) IX and XII isoforms are over-expressed both in primary and in metastatic cell lines of hypoxic tumors and are innovative targets for cancer diagnosis and treatment. On the basis of the importance of the pharmacophoric sulfamate moiety (bioisostere of the sulfonamide group) present in the structure of recent human CA inhibitors, we designed N-alkylated and O-allcylated derivatives of acesulfame, a cyclic tertiary sulfamate, assessing the inhibitory activity against the ubiquitous isoforms hCA I and II and the cancer-related isoforms hCA IX and XII. All derivatives were nanomolar inhibitors, with some of them possessing an outstanding selectivity towards the tumor-associated hCA IX and/or hCA XII isoforms. (c) 2014 Elsevier Masson SAS. All rights reserved.
机译:碳酸酐酶(hCA)IX和XII亚型在低氧性肿瘤的原发性和转移性细胞系中均过表达,是癌症诊断和治疗的创新目标。根据最近人类CA抑制剂结构中存在的药效氨基磺酸盐部分(磺酰胺基团的生物甾醇)的重要性,我们设计了环戊氨基磺酸乙酰磺胺酯的N-烷基化和O-烯丙基化衍生物,评估了其抑制活性对抗普遍存在的亚型hCA I和II,以及与癌症相关的亚型hCA IX和XII。所有衍生物均为纳摩尔抑制剂,其中一些对肿瘤相关的hCA IX和/或hCA XII亚型具有出色的选择性。 (c)2014年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号